Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Outstanding
Ratios

Alaunos Therapeutics (TCRT) Leases (2019 - 2023)

Historic Leases for Alaunos Therapeutics (TCRT) over the last 10 years, with Q3 2023 value amounting to $1.0 million.

  • Alaunos Therapeutics' Leases fell 5376.06% to $1.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.0 million, marking a year-over-year decrease of 5376.06%. This contributed to the annual value of $2.1 million for FY2022, which is 5167.42% down from last year.
  • Latest data reveals that Alaunos Therapeutics reported Leases of $1.0 million as of Q3 2023, which was down 5376.06% from $1.4 million recorded in Q2 2023.
  • Alaunos Therapeutics' 5-year Leases high stood at $5.4 million for Q2 2021, and its period low was $1.0 million during Q3 2023.
  • Moreover, its 5-year median value for Leases was $2.2 million (2022), whereas its average is $2.8 million.
  • Per our database at Business Quant, Alaunos Therapeutics' Leases soared by 18523.63% in 2021 and then tumbled by 5661.32% in 2022.
  • Over the past 5 years, Alaunos Therapeutics' Leases (Quarter) stood at $1.3 million in 2019, then skyrocketed by 262.43% to $4.6 million in 2020, then dropped by 4.95% to $4.4 million in 2021, then tumbled by 51.67% to $2.1 million in 2022, then plummeted by 51.36% to $1.0 million in 2023.
  • Its Leases was $1.0 million in Q3 2023, compared to $1.4 million in Q2 2023 and $2.0 million in Q1 2023.